Article: Techniques that Enable Rapid Research During Vaccine Development
Authors: Drug Target Review with David Apiyo from Sartorius | Last updated: 09/2022
Overview
Vaccines are vital public health tools for the control and eradication of infectious diseases. Their development typically involves multiple stages, beginning with understanding the mechanisms of infection and host response, followed by the design and development of vaccine candidates.
In this short article, Dr. David Apiyo, Manager, BioA Applications, Sartorius, talks about the advanced technologies that streamline workflows and accelerate vaccine development.
- Document type: Article
- Page count: 2
- Read time: 3 minutes
Key Takeaways:
- The COVID-19 pandemic necessitated rapid methods of vaccine development that cut down timelines while achieving vaccine efficacy.
- Real-time, label-free technologies for measuring binding kinetics can accelerate vaccine research and development workflows.
- The Octet® Bio-Layer Interferometry (BLI) platform allows for rapid at-line evaluation of virus titers and kinetic screening of antibody panels for affinity to virus receptors.
This Resource is Designed for:
- COVID- 19 researchers
- Vaccine developer in Biopharma/Pharma and Biotech & Academic institution
Applications Supported:
- Infectious disease research
- Vaccine tools and development
- Host response